8-K: PACS Group Secures Critical Waivers for Extensive Defaults

PACS Group, Inc. and its subsidiary PACS Holdings, LLC, obtained waivers for numerous defaults under their Credit Agreement and Master Lease, averting immediate financial distress.

Summary

• PACS Group, Inc. (the Company) and PACS Holdings, LLC (the Borrower) entered into a Sixth Amendment to their Amended and Restated Credit Agreement and a corresponding waiver for the Third Consolidated Master Lease on November 26, 2025.
• The Sixth Amendment waived all previously identified defaults and events of default under the Credit Agreement, which were also disclosed in a prior forbearance agreement dated October 21, 2025.
• Key defaults waived included failures related to designating subsidiaries (Immaterial Subsidiary Non-Designation, Specified Conflicted Subsidiary Non-Designation, Incorrect Specified Conflicted Subsidiary Designation), compliance with joinder requirements (Joinder Events of Default), and incorrect representations in compliance certificates for fiscal quarters ending March 31, 2024, June 30, 2024, September 30, 2024, December 31, 2024, and March 31, 2025.
• Other waived defaults involved cash management practices (Cash Management Events of Default) and issues arising from significant transactions like the Covenant Care Transaction (around August 1, 2025) and the Unified Transaction (around September 16, 2025).
• The financial covenant requiring the Company to maintain at least $100 million in unrestricted cash and permitted investments will now only apply prior to the delivery of financial statements for the fiscal quarter ending June 30, 2026.
• The previous Forbearance Agreement, dated October 21, 2025, has been terminated, but certain post-closing covenants, including the delivery of documentation for specified subsidiaries by January 19, 2026, remain in effect.
• As conditions for the amendment, the Company paid an amendment fee of 0.15% of the aggregate Revolving Commitments and ensured a waiver of all existing defaults under the Omega Master Lease was received.

Sentiment

Score: 3

Explanation: While the immediate crisis of default was averted through waivers, the sheer volume and nature of the defaults (including incorrect representations, non-compliance with covenants, and issues related to significant transactions) indicate substantial operational and governance challenges. The temporary relief on the liquidity covenant is a positive, but the underlying issues are concerning and suggest significant risk.

Positives

• The Company successfully secured waivers for a comprehensive list of defaults and events of default under its primary Credit Agreement and Master Lease, preventing immediate acceleration of debt and potential financial distress.
• The termination of the previous Forbearance Agreement indicates a resolution of the immediate crisis and a path forward with lenders.
• The temporary modification of the minimum liquidity covenant, which will only apply until the delivery of Q2 2026 financial statements, provides the Company with some operational flexibility and breathing room.

Negatives

• The Company incurred a significant number of defaults across multiple categories, including failures in subsidiary designation, compliance with covenants, cash management, and providing incorrect representations in compliance certificates for five consecutive fiscal quarters.
• The extensive nature of the defaults suggests systemic issues in internal controls, compliance, and potentially financial reporting accuracy.
• The need for a forbearance agreement and subsequent comprehensive waiver indicates a period of significant financial and operational stress for the Company.
• An amendment fee of 0.15% of the aggregate Revolving Commitments was paid, representing a cost to the Company.

Risks

• The numerous past defaults related to subsidiary designation and compliance indicate a risk of ongoing operational and regulatory non-compliance if internal controls are not significantly strengthened.
• Incorrect representations in compliance certificates for multiple fiscal quarters highlight a risk of inaccurate financial reporting and potential future restatements or regulatory scrutiny.
• The Company still has a deadline of January 19, 2026, to deliver required documentation for certain subsidiaries, with failure resulting in an Event of Default.
• While defaults were waived, the underlying issues that led to them could recur, posing a risk to future financial stability and relationships with lenders.
• The amendments to default clauses related to Health Care Permits and payments to Governmental Authorities (exceeding $50 million) suggest potential past or ongoing issues in these areas, which could carry significant financial and reputational risks.

Future Outlook

The Company has secured temporary relief from a critical liquidity covenant until mid-2026, providing some operational flexibility. However, it faces an immediate deadline of January 19, 2026, to complete documentation for certain subsidiaries, with non-compliance leading to a new event of default. The resolution of past defaults allows the Company to move forward, but sustained compliance and improved internal controls will be crucial for its long-term stability.

Management Comments

• The Borrower acknowledges and agrees that the Specified Events of Default have occurred and constitute Events of Default under the Credit Agreement (or, in the case of the Potential Additional Defaults and Events of Default, may have occurred and, if so, constitute Defaults or Events of Default, as applicable, under the Credit Agreement).

Industry Context

The filing highlights the complex compliance and operational challenges faced by large healthcare facility operators, particularly those involved in frequent acquisitions and managing numerous subsidiaries. The issues with subsidiary designation, compliance certificates, and cash management reflect the intricate regulatory environment and the need for robust internal controls in the healthcare sector. The transactions mentioned, such as the Covenant Care and Unified Transactions, indicate ongoing consolidation and expansion within the industry, which can exacerbate compliance complexities.

Comparison to Industry Standards

• The extensive list of defaults, particularly those related to subsidiary designation and compliance certificate accuracy over multiple quarters, suggests a significant deviation from best practices in corporate governance and financial reporting typically expected of publicly traded companies in the healthcare sector.
• While securing waivers for defaults is a common mechanism for companies facing temporary challenges, the sheer volume and nature of the 'Specified Events of Default' indicate a level of internal control weakness that is generally below industry standards for well-managed healthcare providers.
• The temporary relief on the $100 million liquidity covenant, while beneficial, does not align with the robust, consistent financial health indicators often seen in top-tier comparable companies like HCA Healthcare or Universal Health Services, which typically maintain strong, consistent liquidity positions without needing covenant waivers.

Corporate Governance

Stakeholder Impact

• Shareholders: Relief from immediate default, but the extensive list of past defaults indicates significant operational and compliance risks that could impact future performance and share price. The company's ability to manage complex structures and comply with agreements is under scrutiny.
• Lenders: Agreed to waive defaults, indicating continued support but likely with increased scrutiny and potentially higher future borrowing costs. Received an amendment fee.
• Management: The numerous defaults reflect poorly on past management oversight and compliance. The successful negotiation of waivers demonstrates an ability to manage crises, but the focus must now shift to preventing recurrence.
• Employees: No direct impact mentioned, but operational issues and financial instability could indirectly affect job security or company morale.
• Customers/Patients: No direct impact mentioned, but operational and compliance issues in a healthcare setting could indirectly affect service quality or regulatory standing.

Next Steps

• Deliver all required documentation with respect to each Specified Joinder Subsidiary and each Subsidiary listed on Schedule VII to the Forbearance Agreement to the Administrative Agent no later than January 19, 2026.
• Maintain unrestricted cash and permitted investments of at least $100 million until the Company delivers financial statements for the fiscal quarter ending June 30, 2026.

Key Dates

Recommendation

The company successfully secured waivers for a multitude of defaults, which prevents immediate financial distress and potential acceleration of debt. This is a critical positive. However, the sheer volume and nature of the defaults, spanning compliance, subsidiary management, cash management, and even misrepresentations in financial certificates over several quarters, point to deep-seated operational and governance weaknesses. While the immediate crisis is averted, the company's ability to maintain compliance and execute its strategy without recurring issues remains a significant concern. The temporary relief on the liquidity covenant provides some breathing room but doesn't resolve the underlying issues. Investors should hold and monitor closely for evidence of improved internal controls and sustained compliance before considering further investment.

Keywords

Credit Agreement, Waiver, Defaults, SEC Filing, Corporate Governance, Financial Covenants, Liquidity, Healthcare Facilities, Compliance, Forbearance Agreement, Master Lease